Abstract: To provide a thermoplastic resin composition having an enhanced cleaning performance for cleaning a molding processing machine. The thermoplastic resin composition for cleaning a molding processing machine contains (A) an olefin-based resin, and (B) (B1) a nonionic surfactant having an HLB of 13 to 20, wherein the composition contains component (B) in an amount of 0.5 to 10 parts by mass relative to 100 parts by mass of component (A).

Abstract: Provided are a non-human model animal of a retinal vascular disease that can favorably show symptoms similar to those of human retinal vascular diseases such as human diabetic retinopathy, and a method for producing the non-human model animal. In particular, provided are a non-human model animal that is suitable for establishing a method for treating, preventing, or diagnosing retinal edema, which causes highly impaired vision, and a method for producing the non-human model animal. A method for screening a drug for treating and preventing a retinal vascular disease, the method using a non-human model animal, is provided. Provided are a non-human model animal of a retinal vascular disease in which constitutively active Akt is expressed, a method for producing a non-human model animal of a retinal vascular disease in which constitutively active Akt is expressed, and a method for screening a drug for treating or preventing a retinal vascular disease.

Abstract: To provide a thermoplastic resin composition having an enhanced cleaning performance for cleaning a molding processing machine. The thermoplastic resin composition for cleaning a molding processing machine contains (A) an olefin-based resin, and (B) (B1) a nonionic surfactant having an HLB of 13 to 20, wherein the composition contains component (B) in an amount of 0.5 to 10 parts by mass relative to 100 parts by mass of component (A).

Abstract: This filtration treatment system is provided with a membrane filtration device as a prefiltration treatment device for removing insoluble components from the water to be treated containing organic substance, a reverse osmosis membrane treatment device for subjecting the prefiltration-treated water to reverse osmosis membrane treatment, and a chemical agent supply pipe for supplying a chemical agent into the membrane filtration device, wherein the chemical agent contains a sulfamic acid compound, and a bromine-based oxidizing agent or the reaction product of a bromine compound with a chlorine-based oxidizing agent, or, contains the reaction product of a sulfamic acid compound with a bromine-based oxidizing agent or with the reaction product of a bromine compound with a chlorine-based oxidizing agent.

Abstract: Provided are a non-human model animal of a retinal vascular disease that can favorably show symptoms similar to those of human retinal vascular diseases such as human diabetic retinopathy, and a method for producing the non-human model animal. In particular, provided are a non-human model animal that is suitable for establishing a method for treating, preventing, or diagnosing retinal edema, which causes highly impaired vision, and a method for producing the non-human model animal. A method for screening a drug for treating and preventing a retinal vascular disease, the method using a non-human model animal, is provided. Provided are a non-human model animal of a retinal vascular disease in which constitutively active Akt is expressed, a method for producing a non-human model animal of a retinal vascular disease in which constitutively active Akt is expressed, and a method for screening a drug for treating or preventing a retinal vascular disease.

Abstract: This filtration treatment system is provided with a membrane filtration device as a prefiltration treatment device for removing insoluble components from the water to be treated containing organic substance, a reverse osmosis membrane treatment device for subjecting the prefiltration-treated water to reverse osmosis membrane treatment, and a chemical agent supply pipe for supplying a chemical agent into the membrane filtration device, wherein the chemical agent contains a sulfamic acid compound, and a bromine-based oxidizing agent or the reaction product of a bromine compound with a chlorine-based oxidizing agent, or, contains the reaction product of a sulfamic acid compound with a bromine-based oxidizing agent or with the reaction product of a bromine compound with a chlorine-based oxidizing agent.

Abstract: A fluid ejection device includes a fluid chamber configured to store fluid, a nozzle configured to eject the fluid stored in the fluid chamber, a fluid supply channel connected to the fluid chamber and configured to supply the fluid to the fluid chamber, an air bubbles generating member configured to generate air bubbles in the fluid chamber, and a partitioning wall portion configured to separate the fluid chamber and the fluid supply channel, support the air bubbles generating member. The partitioning wall portion include at least one hole, communicating the fluid chamber and the fluid supply channel. The hole is configured to inhibit backflow during ejection of a jet pulse.

Abstract: A fluid ejection device includes a fluid chamber configured to store fluid, a nozzle configured to eject the fluid stored in the fluid chamber, a fluid supply channel connected to the fluid chamber and configured to supply the fluid to the fluid chamber, an air bubbles generating member configured to generate air bubbles in the fluid chamber, and a partitioning wall portion configured to separate the fluid chamber and the fluid supply channel, support the air bubbles generating member. The partitioning wall portion include at least one hole, communicating the fluid chamber and the fluid supply channel. The hole is configured to inhibit backflow during ejection of a jet pulse.

Abstract: A fluid ejection device includes a fluid chamber configured to store fluid, a nozzle configured to eject the fluid stored in the fluid chamber, a fluid supply channel connected to the fluid chamber and configured to supply the fluid to the fluid chamber, an air bubbles generating member configured to generate air bubbles in the fluid chamber, and a partitioning wall portion configured to separate the fluid chamber and the fluid supply channel, support the air bubbles generating member. The partitioning wall portion include at least one hole, communicating the fluid chamber and the fluid supply channel. The hole is configured to inhibit backflow during ejection of a jet pulse.

Abstract: It was found that TAT which has not been known biological activity has a role as a new blood vessel smooth muscle proliferation factor, and then a screening method vascular of an inhibitor or promoter of a smooth muscle cell growth with TAT is established.

Abstract: It was found that TAT which has not been known biological activity has a role as a new blood vessel smooth muscle proliferation factor, and then a screening method vascular of an inhibitor or promoter of a smooth muscle cell growth with TAT is established.

Abstract: A mechanical supercharger of an internal combustion engine has a housing formed with inlet and outlet ports and a pair of spiral screws rotatably received in the housing for partially compressing air introduced in the mechanical supercharger and carrying it from the inlet port to the outlet port. The supercharger is disposed after a throttle valve in an intake system of the engine, and is provided with a relief port allowing compressed air to be relieved from the supercharger. The relief port is formed in the housing between the inlet and outlet ports where air is compressed to allow compressed air to be relieved. A relief valve is controlled to variably open according to engine operating conditions and relieve compressed air in the supercharger.

Abstract: A novel hydrophilic composite porous membrane is obtained by applying a specific copolymer solution onto the overall surface of an oriented polyolefin membranous matrix comprising a plurality of microfibrils and a plurality of knotted portions cross-connected to the microfibrils, followed by drying. The copolymer is water-insoluble and is comprised of hydrophilic monomeric units and hydrophobic monomeric units in a specific ratio. In the obtained composite porous membrane, the microfibrils are bonded together by means of the copolymer, thereby forming bundles and a coat of the copolymer is formed on the overall surface of the bundles and knotted portions. The membrane has therewithin pores which are substantially elliptic in the cross section taken along the same direction as the longitudinal direction of the microfibril bundles and has on both surfaces thereof openings which are substantially elliptic as viewed against the surface of the membrane.